Procyon Advisors’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $340K | Sell |
4,862
-32,992
| -87% | -$2.31M | 0.03% | 345 |
|
|
2025
Q1 | $2.78M | Buy |
37,854
+4,159
| +12% | +$306K | 0.17% | 129 |
|
|
2024
Q4 | $2.21M | Buy |
33,695
+3,842
| +13% | +$252K | 0.14% | 148 |
|
|
2024
Q3 | $2.33M | Buy |
29,853
+3,270
| +12% | +$255K | 0.16% | 143 |
|
|
2024
Q2 | $2.07M | Buy |
26,583
+2,033
| +8% | +$159K | 0.15% | 148 |
|
|
2024
Q1 | $1.66M | Buy |
24,550
+3,438
| +16% | +$233K | 0.13% | 170 |
|
|
2023
Q4 | $1.42M | Buy |
21,112
+15,970
| +311% | +$1.08M | 0.12% | 178 |
|
|
2023
Q3 | $348K | Buy |
5,142
+1,394
| +37% | +$94.4K | 0.04% | 362 |
|
|
2023
Q2 | $268K | Buy |
3,748
+24
| +0.6% | +$1.72K | 0.03% | 375 |
|
|
2023
Q1 | $258K | Sell |
3,724
-595
| -14% | -$41.3K | 0.04% | 330 |
|
|
2022
Q4 | $293K | Buy |
4,319
+93
| +2% | +$6.31K | 0.05% | 298 |
|
|
2022
Q3 | $232K | Sell |
4,226
-23
| -0.5% | -$1.26K | 0.06% | 282 |
|
|
2022
Q2 | $281K | Sell |
4,249
-170
| -4% | -$11.2K | 0.06% | 260 |
|
|
2022
Q1 | $293K | Sell |
4,419
-853
| -16% | -$56.6K | 0.06% | 261 |
|
|
2021
Q4 | $307K | Buy |
5,272
+406
| +8% | +$23.6K | 0.07% | 252 |
|
|
2021
Q3 | $292K | Sell |
4,866
-72
| -1% | -$4.32K | 0.07% | 237 |
|
|
2021
Q2 | $296K | Buy |
4,938
+110
| +2% | +$6.59K | 0.08% | 221 |
|
|
2021
Q1 | $240K | Hold |
4,828
| – | – | 0.11% | 209 |
|
|
2020
Q4 | $241K | Buy |
4,828
+241
| +5% | +$12K | 0.12% | 196 |
|
|
2020
Q3 | $251K | Sell |
4,587
-1,268
| -22% | -$69.4K | 0.14% | 160 |
|
|
2020
Q2 | $310K | Sell |
5,855
-242
| -4% | -$12.8K | 0.16% | 124 |
|
|
2020
Q1 | $272K | Sell |
6,097
-100
| -2% | -$4.46K | 0.18% | 111 |
|
|
2019
Q4 | $309K | Buy |
+6,197
| New | +$309K | 0.19% | 109 |
|